JP2021512921A5 - - Google Patents
Info
- Publication number
- JP2021512921A5 JP2021512921A5 JP2020542862A JP2020542862A JP2021512921A5 JP 2021512921 A5 JP2021512921 A5 JP 2021512921A5 JP 2020542862 A JP2020542862 A JP 2020542862A JP 2020542862 A JP2020542862 A JP 2020542862A JP 2021512921 A5 JP2021512921 A5 JP 2021512921A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- administered
- product according
- day
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862629579P | 2018-02-12 | 2018-02-12 | |
| US62/629,579 | 2018-02-12 | ||
| PCT/US2019/017430 WO2019157423A1 (en) | 2018-02-12 | 2019-02-11 | Methods and dosing regimens using ibudilast and a second agent for cancer therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021512921A JP2021512921A (ja) | 2021-05-20 |
| JP2021512921A5 true JP2021512921A5 (cg-RX-API-DMAC7.html) | 2022-02-17 |
Family
ID=67542181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542862A Pending JP2021512921A (ja) | 2018-02-12 | 2019-02-11 | 癌療法に対するイブジラストおよび第二の薬剤を使用した方法ならびに投与レジメン |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10744123B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3752147A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021512921A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112236140A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3090884A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019157423A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3090884A1 (en) * | 2018-02-12 | 2019-08-15 | Medicinova, Inc. | Methods and dosing regimens using ibudilast and a second agent for cancer therapy |
| JP2024528731A (ja) | 2021-07-26 | 2024-07-30 | メディシノバ・インコーポレイテッド | 眼癌転移を予防するためのイブジラスト |
| CN113584172B (zh) * | 2021-08-04 | 2022-08-02 | 中南大学湘雅二医院 | Slc12a5及其抑制剂的应用 |
| CA3231869A1 (en) * | 2021-09-21 | 2023-03-30 | Medicinova, Inc. | Ibudilast in combination therapy for use in the treatment of glioblastoma |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8562198A (en) | 1998-08-10 | 2000-03-06 | Kyorin Pharmaceutical Co. Ltd. | Remedies for multiple sclerosis |
| WO2006063048A2 (en) | 2004-12-06 | 2006-06-15 | Avigen, Inc. | Ibudilast for treating neuropathic pain and associated syndromes |
| TW200716141A (en) * | 2005-05-05 | 2007-05-01 | Combinatorx Inc | Compositions and methods for treatment for neoplasms |
| CA2693697C (en) * | 2007-07-11 | 2017-07-25 | Medicinova, Inc. | Treatment of progressive neurodegenerative disease with ibudilast |
| CN115778934A (zh) * | 2012-01-20 | 2023-03-14 | 德玛公司 | 经取代的己糖醇类用于治疗恶性肿瘤的用途 |
| US20160361298A1 (en) * | 2015-06-11 | 2016-12-15 | Globavir Biosciences, Inc. | Methods and compositions for treating cancer |
| EP3558301A4 (en) * | 2016-12-22 | 2020-07-29 | MediciNova, Inc. | METHOD FOR TREATING GLIOBLASTOMA MULTIFORME WITH IBUDILAST |
| CA3090884A1 (en) * | 2018-02-12 | 2019-08-15 | Medicinova, Inc. | Methods and dosing regimens using ibudilast and a second agent for cancer therapy |
-
2019
- 2019-02-11 CA CA3090884A patent/CA3090884A1/en active Pending
- 2019-02-11 JP JP2020542862A patent/JP2021512921A/ja active Pending
- 2019-02-11 EP EP19751704.8A patent/EP3752147A4/en not_active Withdrawn
- 2019-02-11 CN CN201980022054.9A patent/CN112236140A/zh active Pending
- 2019-02-11 WO PCT/US2019/017430 patent/WO2019157423A1/en not_active Ceased
- 2019-02-11 US US16/272,694 patent/US10744123B2/en active Active
-
2020
- 2020-07-10 US US16/926,441 patent/US11446283B2/en active Active